Low-grade B-Cell lymphomas with plasmacytic differentiation lack PAX5 gene rearrangements
- PMID: 16049306
- PMCID: PMC1867539
- DOI: 10.1016/S1525-1578(10)60563-6
Low-grade B-Cell lymphomas with plasmacytic differentiation lack PAX5 gene rearrangements
Abstract
The chromosomal translocation t(9;14)(p13;q32) has been reported in association with lymphoplasmacytic lymphoma (LPL). Although this translocation involving the paired homeobox-5 (PAX5) gene at chromosome band 9p13 and the immunoglobulin heavy chain (IgH) gene at 14q32 has been described in approximately 50% of LPL cases, the actual number of cases studied is quite small. Many of the initial cases associated with t(9;14)(p13;q32) were actually low-grade B-cell lymphomas with plasmacytic differentiation other than LPL. Thus, we analyzed a series of low-grade B-cell lymphomas for PAX5 gene rearrangements. We searched records from the Department of Pathology, Stanford University Medical Center for low-grade B-cell lymphomas, with an emphasis on plasmacytic differentiation, that had available paraffin blocks or frozen tissue. We identified 37 cases, including 13 LPL, 18 marginal zone lymphomas (nodal, extranodal, splenic, and alpha-heavy chain disease), and 6 small lymphocytic lymphomas. A novel dual-color break-apart bacterial artificial chromosome probe was designed to flank the PAX5 gene, spanning previously described PAX5 breakpoints, and samples were analyzed by interphase fluorescence in situ hybridization. All cases failed to demonstrate a PAX5 translocation, indicating that t(9;14)(p13;q32) and other PAX5 translocations are uncommon events in low-grade B-cell lymphomas with plasmacytic differentiation. This study also confirms recent reports that found an absence of PAX5 rearrangements in LPL, suggesting the reassessment of PAX5 rearrangements in LPL.
Figures





Similar articles
-
Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t(9;14).Hum Pathol. 2004 Apr;35(4):447-54. doi: 10.1016/j.humpath.2003.10.014. Hum Pathol. 2004. PMID: 15116325
-
Fluorescence immunophenotypic and interphase cytogenetic characterization of nodal lymphoplasmacytic lymphoma.Am J Surg Pathol. 2008 Nov;32(11):1643-53. doi: 10.1097/PAS.0b013e3181758806. Am J Surg Pathol. 2008. PMID: 18670352
-
PAX5/IGH rearrangement is a recurrent finding in a subset of aggressive B-NHL with complex chromosomal rearrangements.Genes Chromosomes Cancer. 2005 Oct;44(2):218-23. doi: 10.1002/gcc.20214. Genes Chromosomes Cancer. 2005. PMID: 15942942
-
Chromosomal rearrangement of the PAX-5 locus in lymphoplasmacytic lymphoma with t(9;14)(p13;q32).Leuk Lymphoma. 1999 Jun;34(1-2):25-33. doi: 10.3109/10428199909083377. Leuk Lymphoma. 1999. PMID: 10350329 Review.
-
The t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.Leuk Lymphoma. 2000 Feb;36(5-6):435-45. doi: 10.3109/10428190009148390. Leuk Lymphoma. 2000. PMID: 10784387 Review.
Cited by
-
Epstein-Barr virus-positive diffuse large B-cell lymphoma carrying a t(9;14)(p13;q32) translocation.Int J Hematol. 2009 Jun;89(5):704-8. doi: 10.1007/s12185-009-0321-6. Epub 2009 May 12. Int J Hematol. 2009. PMID: 19430986
-
Gamma heavy-chain disease: defining the spectrum of associated lymphoproliferative disorders through analysis of 13 cases.Am J Surg Pathol. 2012 Apr;36(4):534-43. doi: 10.1097/PAS.0b013e318240590a. Am J Surg Pathol. 2012. PMID: 22301495 Free PMC article.
-
Expression of the prosurvival kinase HCK requires PAX5 and mutated MYD88 signaling in MYD88-driven B-cell lymphomas.Blood Adv. 2020 Jan 14;4(1):141-153. doi: 10.1182/bloodadvances.2019000947. Blood Adv. 2020. PMID: 31935288 Free PMC article.
-
Marginal zone B-cell lymphoma mimicking extramedullary plasmacytoma and the clinical outcome after treatment.Arch Med Sci. 2017 Apr 1;13(3):698-701. doi: 10.5114/aoms.2017.67290. Epub 2017 Apr 20. Arch Med Sci. 2017. PMID: 28507591 Free PMC article. No abstract available.
-
Plasma cells arise from differentiation of clonal lymphocytes and secrete IgM in Waldenström macroglobulinemia.iScience. 2022 Aug 4;25(8):104856. doi: 10.1016/j.isci.2022.104856. eCollection 2022 Aug 19. iScience. 2022. PMID: 35992066 Free PMC article.
References
-
- Cook JR, Aguilera NI, Reshmi-Skarja S, Huang X, Yu Z, Gollin SM, Abbondanzo SL, Swerdlow SH. Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t(9;14). Hum Pathol. 2004;35:447–454. - PubMed
-
- Schop RFJ, Kuehl WM, Van Wier SA, Ahmann GJ, Price-Troska T, Bialey RJ, Jala SM, Qi Y, Kyle RA, Greipp PR, Fonseca R. Waldenstrom macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions. Blood. 2002;100:2996–3001. - PubMed
-
- Mansoor A, Medeiros LJ, Weber DM, Alexanian R, Hayes K, Jones D, Lai R, Glassman A, Bueso-Ramos CE. Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia. Am J Clin Pathol. 2001;116:543–549. - PubMed
-
- Ohno H, Furukawa T, Fukuhara S, Zong SQ, Kamesaki H, Shows TB, Le Beau MM, McKeithan TW, Kawakami TT, Honjo T. Molecular analysis of a chromosomal translocation, t(9;14)(p13;q32), in a diffuse large-cell lymphoma cell line expressing the Ki-1 antigen. Proc Natl Acad Sci USA. 1990;87:628–632. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials